- Home
- HROW vs ATEN Comparison
HROW vs ATEN Comparison
Compare HROW & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- ATEN
- Stock Information
- Founded
- HROW 1998
- ATEN 2004
- Country
- HROW United States
- ATEN United States
- Employees
- HROW N/A
- ATEN N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- ATEN EDP Services
- Sector
- HROW Health Care
- ATEN Technology
- Exchange
- HROW Nasdaq
- ATEN Nasdaq
- Market Cap
- HROW 1.1B
- ATEN 1.3B
- IPO Year
- HROW N/A
- ATEN 2014
- Fundamental
- Price
- HROW $30.66
- ATEN $17.78
- Analyst Decision
- HROW Strong Buy
- ATEN Buy
- Analyst Count
- HROW 6
- ATEN 2
- Target Price
- HROW $59.00
- ATEN $21.00
- AVG Volume (30 Days)
- HROW 433.0K
- ATEN 595.1K
- Earning Date
- HROW 08-06-2025
- ATEN 07-29-2025
- Dividend Yield
- HROW N/A
- ATEN 1.35%
- EPS Growth
- HROW N/A
- ATEN 9.85
- EPS
- HROW N/A
- ATEN 0.67
- Revenue
- HROW $212,858,000.00
- ATEN $267,158,000.00
- Revenue This Year
- HROW $44.92
- ATEN $9.40
- Revenue Next Year
- HROW $38.12
- ATEN $7.66
- P/E Ratio
- HROW N/A
- ATEN $26.47
- Revenue Growth
- HROW 53.49
- ATEN 4.90
- 52 Week Low
- HROW $19.31
- ATEN $12.27
- 52 Week High
- HROW $59.23
- ATEN $21.90
- Technical
- Relative Strength Index (RSI)
- HROW 57.58
- ATEN 52.36
- Support Level
- HROW $30.01
- ATEN $17.64
- Resistance Level
- HROW $31.63
- ATEN $18.48
- Average True Range (ATR)
- HROW 1.59
- ATEN 0.40
- MACD
- HROW 0.02
- ATEN -0.02
- Stochastic Oscillator
- HROW 66.10
- ATEN 46.99
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.